OBJECTIVES The goal of this study was to assess the relationship among extracellular volume (ECV), native T1, and systolic strain in hypertensive patients with left ventricular hypertrophy (HTN LVH), hypertensive patients without LVH (HTN non-LVH), and normotensive controls.
H ypertension (HTN) is a common cause of morbidity and mortality in the United
States affecting 1 in 3 adults (1). Patients with long-standing or poorly controlled HTN are at increased risk for developing left ventricular hypertrophy (LVH) and diastolic dysfunction (2) . LVH is an independent risk factor for cardiovascular morbidity and mortality in hypertensive patients (3, 4) . Diffuse fibrosis has been detected in subjects with HTN with LVH in both biopsy (5) and autopsy studies (6) and has been linked to the development of LVH and diastolic dysfunction (7) . Concentric LVH portends higher cardiovascular morbidity and mortality compared with other hypertrophy subtypes (8) .
The presence of diffuse fibrosis may confer increased cardiovascular risk in HTN LVH patients.
Diffuse myocardial fibrosis in hypertensive LVH is not detected by conventional late gadolinium enhanced (LGE) cardiac magnetic resonance (CMR).
T1 mapping is a novel CMR approach that is able to detect diffuse fibrosis in diseases such as aortic stenosis and hypertrophic cardiomyopathy as validated against myocardial biopsy (9) . By measuring the T1 relaxation times of the blood and myocardium both pre-and post-contrast, one can determine the partition coefficient (l) of gadolinium and, subsequently, the extracellular volume (ECV).
We hypothesized that HTN LVH patients would show diffuse myocardial fibrosis as measured by T1 mapping and ECV compared with HTN non-LVH and normotensive controls. We also postulated that subjects with HTN LVH would have greater fibrosis and reduced systolic strain, and early diastolic strain rate compared with the other 2 groups. 
METHODS

Twenty subjects with HTN LVH (mean age
Kuruvilla et al. Peak systolic circumferential strain and early diastolic strain rates were computed offline from cine displacement encoding with stimulated echo images with a custom MATLAB script using previously described methods (18, 19) .
STATISTICAL ANALYSIS. All continuous variables are expressed as their mean and standard deviation.
All statistical analysis was performed using SPSS version 21 (IBM Corporation, Armonk, New York).
Values were compared between groups using 1-way analysis of variance, the Scheffe method was used to control for multiple pairwise corrections. Age and number of blood pressure medications for the 3 groups as shown in Table 1 were reported as median scores with interquartile ranges. Comparisons between groups of non-normally distributed variables were performed using the Kruskal-Wallis test. Correlation analysis used the Pearson correlation coefficient for linear associations, and the Spearman rank correlation coefficient for monotonic nonlinear associations. A p value <0.05 was considered significant. Table 1 shows the baseline characteristics of the 3 groups. The groups had similar values for heart rate, LVEF, and Hct. The systolic and diastolic blood pressures were significantly higher in the HTN LVH group than the HTN non-LVH and control subjects.
RESULTS
LV mass was higher in the HTN LVH group by study design. Two subjects (both in the HTN non-LVH group) had focal areas of late enhancement: Figure 2 ). There were no differences in ECV (p ¼ 0.6) between HTN non-LVH and control subjects. Similar findings were seen with partition coefficient (l) ( Table 2 ) (Online Appendix).
NATIVE T1. The native T1 of the patients with HTN LVH was longer than that of control subjects (996 AE 32 vs. 967 AE 35, p ¼ 0.007) ( Table 2) . Although the point estimate of native T1 in the HTN non-LVH group was higher than that of controls, this difference was not statistically significant ( Table 2) . Post-contrast T1
values are provided in the data supplement. Figure 4A shows average circumferential strain-time curves from the 3 groups.
Peak circumferential strain at both base and midventricular levels was reduced in HTN LVH subjectscompared with both controls and HTN non-LVH subjects ( Table 3) . ECV correlated with peak circum- Table 3) . The results were similar for early diastolic circumferential strain rates at both the basal and mid-ventricular levels ( Table 3) 
DISCUSSION
In this study, T1 mapping by CMR showed greater diffuse fibrosis as measured by ECV in subjects with HTN LVH compared with HTN non-LVH and control This is the first study to measure the level of diffuse fibrosis using ECV in HTN LVH subjects compared with HTN non-LVH subtypes using a noninvasive imaging method. HTN LVH subjects in this study had greater diffuse fibrosis as measured by ECV. The presence of diffuse fibrosis may be an underlying mechanism contributing to the increased cardiovascular risk in HTN LVH subjects, and therapies that modify diffuse fibrosis may affect the risk.
The link between diffuse fibrosis and increased cardiovascular risk was examined in a recent study (25) of heart failure patients with preserved EF and found that shortened post-contrast T1 times, a marker of diffuse fibrosis, was associated with increased cardiac events.
Although there is greater diffuse fibrosis in HTN LVH subjects, the association between ECV and LVMI is nonlinear suggesting that there may be differential stimulation of fibrosis and myocyte hypertrophy in these patients. The HTN non-LVH subjects had better controlled blood pressures, and their LV mass was not significantly higher than that of control subjects.
Fibrosis in these subjects was similar to that of controls, and the lack of fibrosis may be related to the lower risk of cardiovascular events for this group. does not permit the measure of uncertainty of the fit and may be more sensitive to measurement outliers.
Two of our control subjects as mentioned in the preceding text had elevated ECV levels, and it is unclear whether these results are due to normal variation or due to undetermined pathologies.
FUTURE DIRECTIONS. There are limited data on the prognostic value of diffuse fibrosis as measured by ECV in hypertensive subjects. Additionally, the prognostic value of native T1 levels has yet to be studied in this study population. Although diffuse fibrosis in HTN LVH subjects may be an underlying mechanism that explains the increased cardiovascular morbidity and mortality seen in these subjects, further studies are needed to conclusively link the presence of diffuse fibrosis with hard outcomes in these patients. Currently, only 1 study has evaluated the prognostic capability of T1 mapping in predicting cardiovascular events in a similar study population (25) . 
CONCLUSIONS
